SoWell-Learn: WELL-being Improvement Following Sophrology Practice

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05888415
Collaborator
(none)
60
1
24
2.5

Study Details

Study Description

Brief Summary

Stress and psychosocial risks are a major public health problem.Sophrology is a psycho-corporal method exclusively verbal and non-tactile used as a therapeutic technique. It combines a set of techniques that will act both on the body and on the mind through breathing exercises, muscle relaxation and mental imagery (or visualization). It allows to find a state of well-being and to activate all physical and psychological potential in order to acquire a better knowledge of oneself. Sophrology demonstrated some benefits on symptoms of patients. However, these approaches have never been evaluated with a prolonged follow-up of several months, with biological measures or with adjustments according to the levels of mastery of sophrology. This project proposes to evaluate the effects of sophrology practice. The investigators aim to evaluate both subjective and objective measures of stress.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Those interested in participating in the study will contact the investigators via the email address provided on the flyer. A clinical research associate will contact them and give them an appointment at the Institute of Occupational Medicine, Faculty of Medicine, 28 place Henri Dunant, 63000 Clermont-Ferrand, in order to provide them with informed information and respond to their their questions.

    If participants agree to participate, the clinical research associate will provide them with the saliva collection kit with instructions for use and a Redcap® link to inform their commitment, and complete an inclusion questionnaire and the first main questionnaire. Then, the participants will receive the questionnaire directly by email for the following fillings.

    When accessing Redcap®, a brief description of the study will again be provided. We will ask the participant to commit to their group's inclusion criteria by checking a box. The non-opposition will be collected by clicking on "envoyer" at the end of the information letter. The following sentence will be indicated "In the case of an agreement please click on the button "envoyer".

    After collection of the non-opposition, participant will have to completed a short inclusion questionnaire composed of:

    • Initials for create an ID

    • Sociodemographic variables: gender, age, marital status, children, occupation, and recent stressful event.

    • Group : " pratiquant " or " non pratiquant ". For those practicing sophrology: type of practice and number of years of practice

    • Realization of another wellness practice

    • Email address to be able to receive the questionnaires each month by automatic sending. In order to guarantee anonymity, the email address of the participants will not be accessible to the investigators / collaborators of the study. They will thus be contacted by email directly by REDCap® for the questionnaire filling (identical questionnaire each month during 6 months).

    The self-administered main questionnaire will be composed of:
    • Information about saliva sampling: Date and time of collection, Time of awakening on day of collection, Eppendorf number

    • Visual analog scales assessing the perceived stress, anxiety, sleep quality, fatigue, time judgment and emotions on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100).

    • Lifestyle variables: treatment, physical activity, addiction (alcohol, cannabis, and tobacco), coffee/tea and food intake.

    • Sophrology practice: Number of sessions per week, type of practice, stress before and after the last sophrology session, realization of another wellness practice

    Furthermore, each participant will do a self-collection of saliva the first week of each month, upon waking up, on a day of the week chosen by the participant as being as reproducible as possible. Participants will have to keep the samples in their freezer and bring them back to us in an ice pack at the end of the 6 months. For this purpose, in the last questionnaire, we will display a window asking them to contact us to organise the return of their saliva samples.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    WELL-being Improvement Following Sophrology Practice
    Anticipated Study Start Date :
    Sep 1, 2023
    Anticipated Primary Completion Date :
    Sep 1, 2024
    Anticipated Study Completion Date :
    Sep 1, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    sophrology practitioners

    Practice sophrology - no intervention

    non practitioners

    Do not practice sophrology - no intervention

    Outcome Measures

    Primary Outcome Measures

    1. DHEAS [Baseline]

      Stress measure objectively using dheas measured in pg/ml

    2. Cortisol [Baseline]

      Stress measure objectively using cortisol measured in µg/dl

    3. Leptine [Baseline]

      Stress measure objectively using leptin measured in ng/ml

    4. Ghrelin [Baseline]

      Stress measure objectively using ghrelin measured in pg/ml

    5. DHEAS [month 1]

      Stress measure objectively using dheas measured in pg/ml

    6. Cortisol [month 1]

      Stress measure objectively using cortisol measured in µg/dl

    7. Leptin [month 1]

      Stress measure objectively using leptin measured in ng/ml

    8. Ghrelin [month 1]

      Stress measure objectively using ghrelin measured in pg/ml

    9. DHEAS [month 2]

      Stress measure objectively using dheas measured in pg/ml

    10. Cortisol [month 2]

      Stress measure objectively using cortisol measured in µg/dl

    11. Leptin [month 2]

      Stress measure objectively using leptin measured in ng/ml

    12. Ghrelin [month 2]

      Stress measure objectively using ghrelin measured in pg/ml

    13. DHEAS [month 3]

      Stress measure objectively using dheas measured in pg/ml

    14. Cortisol [month 3]

      Stress measure objectively using cortisol measured in µg/dl

    15. Leptin [month 3]

      Stress measure objectively using leptin measured in ng/ml

    16. Ghrelin [month 3]

      Stress measure objectively using ghrelin measured in pg/ml

    17. DHEAS [month 4]

      Stress measure objectively using dheas measured in pg/ml

    18. Cortisol [month 4]

      Stress measure objectively using cortisol measured in µg/dl

    19. Leptin [month 4]

      Stress measure objectively using leptin measured in ng/ml

    20. Ghrelin [month 4]

      Stress measure objectively using ghrelin measured in pg/ml

    21. DHEAS [month 5]

      Stress measure objectively using dheas measured in pg/ml

    22. Cortisol [month 5]

      Stress measure objectively using cortisol measured in µg/dl

    23. Leptin [month 5]

      Stress measure objectively using leptin measured in ng/ml

    24. Ghrelin [month 5]

      Stress measure objectively using ghrelin measured in pg/ml

    25. DHEAS [month 6]

      Stress measure objectively using dheas measured in pg/ml

    26. Cortisol [month 6]

      Stress measure objectively using cortisol measured in µg/dl

    27. Leptin [month 6]

      Stress measure objectively using leptin measured in ng/ml

    28. Ghrelin [month 6]

      Stress measure objectively using ghrelin measured in pg/ml

    29. Subjective stress [Baseline]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    30. Subjective stress [Month 1]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    31. Subjective stress [Month 2]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    32. Subjective stress [Month 3]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    33. Subjective stress [Month 4]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    34. Subjective stress [Month 5]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    35. Subjective stress [Month 6]

      stress measure subjectively using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    Secondary Outcome Measures

    1. Sociodemographic [once at baseline]

      gender, age, marital status, children, occupation, and recent stressful event

    2. Sophrology practice [once at baseline]

      Type of sophrology practice using a multiple-choice question

    3. Drug treatment [Baseline]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc."

    4. Drug treatment [Month 1]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc."

    5. Drug treatment [Month 2]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc."

    6. Drug treatment [Month 3]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc." If yes, "type of treatment" and "number of tablets per day"

    7. Drug treatment [Month 4]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc."

    8. Drug treatment [Month 5]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc."

    9. Drug treatment [Month 6]

      Multiple-choice question: "Do you take long-term medication? No treatment, Psychotropics, Sleeping pills, Antihypertensives, etc."

    10. Tobacco consumption [Baseline]

      Average number of cigarettes per day over the past month

    11. Coffee consumption [Baseline]

      Average number of cups of coffee per day over the past month

    12. Tea consumption [Baseline]

      Average number of cups of tea per day over the past month

    13. Tobacco consumption [Month 1]

      Average number of cigarettes per day over the past month

    14. Coffee consumption [Month 1]

      Average number of cups of coffee per day over the past month

    15. Tea consumption [Month 1]

      Average number of cups of tea per day over the past month

    16. Tobacco consumption [Month 2]

      Average number of cigarettes per day over the past month

    17. Coffee consumption [Month 2]

      Average number of cups of coffee per day over the past month

    18. Tea consumption [Month 2]

      Average number of cups of tea per day over the past month

    19. Tobacco consumption [Month 3]

      Average number of cigarettes per day over the past month

    20. Coffee consumption [Month 3]

      Average number of cups of coffee per day over the past month

    21. Tea consumption [Month 3]

      Average number of cups of tea per day over the past month

    22. Tobacco consumption [Month 4]

      Average number of cigarettes per day over the past month

    23. Coffee consumption [Month 4]

      Average number of cups of coffee per day over the past month

    24. Tea consumption [Month 4]

      Average number of cups of tea per day over the past month

    25. Tobacco consumption [Month 5]

      Average number of cigarettes per day over the past month

    26. Coffee consumption [Month 5]

      Average number of cups of coffee per day over the past month

    27. Tea consumption [Month 5]

      Average number of cups of tea per day over the past month

    28. Tobacco consumption [Month 6]

      Average number of cigarettes per day over the past month

    29. Coffee consumption [Month 6]

      Average number of cups of coffee per day over the past month

    30. Tea consumption [Month 6]

      Average number of cups of tea per day over the past month

    31. Alcohol consumption [Baseline]

      Average number of alcoholic drinks per week

    32. Cannabis consumption [Baseline]

      Average number of cannabis joints per week

    33. Alcohol consumption [Month 1]

      Average number of alcoholic drinks per week

    34. Cannabis consumption [Month 1]

      Average number of cannabis joints per week

    35. Alcohol consumption [Month 2]

      Average number of alcoholic drinks per week

    36. Cannabis consumption [Month 2]

      Average number of cannabis joints per week

    37. Alcohol consumption [Month 3]

      Average number of alcoholic drinks per week

    38. Cannabis consumption [Month 3]

      Average number of cannabis joints per week

    39. Alcohol consumption [Month 4]

      Average number of alcoholic drinks per week

    40. Cannabis consumption [Month 4]

      Average number of cannabis joints per week

    41. Alcohol consumption [Month 5]

      Average number of alcoholic drinks per week

    42. Cannabis consumption [Month 5]

      Average number of cannabis joints per week

    43. Alcohol consumption [Month 6]

      Average number of alcoholic drinks per week

    44. Cannabis consumption [Month 6]

      Average number of cannabis joints per week

    45. Food consumption [Baseline]

      Average food consumption in the last month

    46. Food consumption [Month 1]

      Average food consumption in the last month

    47. Food consumption [Month 2]

      Average food consumption in the last month

    48. Food consumption [Month 3]

      Average food consumption in the last month

    49. Food consumption [Month 4]

      Average food consumption in the last month

    50. Food consumption [Month 5]

      Average food consumption in the last month

    51. Food consumption [Month 6]

      Average food consumption in the last month

    52. Physical activity [Baseline]

      Average number of hours of physical activity per week over the past month

    53. Physical activity [Month 1]

      Average number of hours of physical activity per week over the past month

    54. Physical activity [Month 2]

      Average number of hours of physical activity per week over the past month

    55. Physical activity [Month 3]

      Average number of hours of physical activity per week over the past month

    56. Physical activity [Month 4]

      Average number of hours of physical activity per week over the past month

    57. Physical activity [Month 5]

      Average number of hours of physical activity per week over the past month

    58. Physical activity [Month 6]

      Average number of hours of physical activity per week over the past month

    59. Well-being [Baseline]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    60. Well-being [Month 1]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    61. Well-being [Month 2]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    62. Well-being [Month 3]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    63. Well-being [Month 4]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    64. Well-being [Month 5]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    65. Well-being [Month 6]

      Well-being measured using a visual analogue scale ranging from 0 (minimum) to 100 (maximum)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion criteria

    For both groups (sophro-practitioners vs. non-practitioners), being able to give informed consent to participate in the research. Commit to respecting the inclusion criteria of their group.

    • For sophro-practitioners:

    • practice at least once a week,

    • practice vertically following the dynamic relaxation method.

    • For non-practitioners, do not practice sophrology during the follow-up. If the participant changes his mind, he will be asked to inform the investigator.

    Exclusion Criteria:
    • Protected persons (minors, pregnant women, breastfeeding women, guardianship, curatorship, deprived of freedoms, safeguard of justice)

    • Refusal to participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU Clemront-Ferrand Clermont-Ferrand France

    Sponsors and Collaborators

    • University Hospital, Clermont-Ferrand

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Clermont-Ferrand
    ClinicalTrials.gov Identifier:
    NCT05888415
    Other Study ID Numbers:
    • RNI 2022 DUTHEIL 2
    First Posted:
    Jun 5, 2023
    Last Update Posted:
    Jun 5, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jun 5, 2023